PA
THRY icon

PharVision Advisers’s Thryv Holdings THRY Stock Holding History

PharVision Advisers’s Portfolio THRY Stock Details THRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,747
Closed -$54.1K – 128
2026
Q1 		$54.1K Buy
19,747
+8,506
+76% +$33.4K 0.55% 84
2025
Q4 		$68K Sell
11,241
-19,778
-64% -$157K 0.03% 664
2025
Q3 		$374K Buy
+31,019
New +$392K 0.21% 106

Other funds holding THRY

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $292M AUM 36.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brooktree Capital Management Gand Rapids, Michigan $153M AUM 14.06% 1-Year Est. Return

PharVision Advisers's THRY Position: Q2 2026 in Review

PharVision Advisers sold out of Thryv Holdings (THRY) in Q2 2026, closing a stake of 19,747 shares — an estimated $54.1K sold.

PharVision Advisers first reported a position in THRY in Q3 2025 and held it in 3 quarters. The position peaked at $374K in Q3 2025. 127 funds tracked by Wall St. Rank hold THRY as of Q2 2026.

  • PharVision Advisers reported no remaining Thryv Holdings position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 19,747 Thryv Holdings shares in Q2 2026, an estimated $54.1K.
  • PharVision Advisers first reported a position in Thryv Holdings in Q3 2025 and held it in 3 quarters.
  • PharVision Advisers's Thryv Holdings position peaked at $374K in Q3 2025.
  • 127 funds tracked by Wall St. Rank held Thryv Holdings as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.